SCHEMBL1958722

SCHEMBL1958722

CNC(=O)c1cccc(Oc2cc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)ccc2C(=O)N[S+]([O-])c2ccc(NCCCN(C)C)c([N+](=O)[O-])c2)c1

nearest known ligand 0.80

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 11/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1958597 0.89 BCL2 (1.00) BCL2
SCHEMBL1956034 0.88 BCL2 (0.69) BCL2
SCHEMBL1958183 0.84 BCL2 (0.63) BCL2
SCHEMBL1959630 0.83 BCL2 (1.00) BCL2
SCHEMBL1956541 0.82 BCL2 (0.97) BCL2
SCHEMBL1959508 0.81 BCL2 (1.00) BCL2
SCHEMBL1955976 0.81 BCL2 (1.00) BCL2
SCHEMBL1956108 0.81 BCL2 (1.00) BCL2
SCHEMBL1958643 0.81 BCL2 (0.93) BCL2
SCHEMBL1958181 0.80 BCL2 (1.00) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2507211-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbott Laboratories (US) 2012-10-10 — — EP disclosed
WO-2011068560-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2011-06-09 — — WO disclosed
Send feedback